Preeclampsia and endometrial cancer risk during pregnancy: a systematic review and meta-analysis | BMC Women’s Health

Sub Levels

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates global incidence and mortality for 36 cancers in 185 countries. CA Cancer J Clinic. 2021 May;71(3):209–49.

  • UK Cancer Research. Uterine cancer incidence statistics. 2021 years.

  • Seer. cancer statistics facts. :Uterine cancer. National Cancer Institute. 574 Bethesda, Maryland. 2022.

  • Linkov F, Edwards R, Bork J, Yurkovetsky Z, Stutterman B, Locsin A, and others. Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research on modifiable risk factors. Euro J Cancer. 2008 Aug;44(12):1632–44.

  • Brinton L. Epidemiology of gynecologic cancer. 6th edition Vol. 7. 2017. 1–23 p.

  • Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, et al. Reproductive risk factors and endometrial cancer: a European prospective study on cancer and nutrition. International J cancer. 2010;127(2):442–51.

    CAS PubMed Google Scholar

  • Troisi R, Bjørge T, Gissler M, Grotmol T, Kitahara CM, Myrtveit Sæther SM and others. Role of pregnancy, perinatal factors, and hormones in maternal cancer risk: A review of the evidence. J intern Doctor of Medicine. 1 May 2018;283(5):430–45.

  • Chappell LC, Cluver CA, Kingdom J, Tong S. Preeclampsia. lancet. 2021 Jul;398(10297):341–54.

  • Hatcheon JA, Risonkoba S, and Joseph KS. Epidemiology of pre-eclampsia and other gestational hypertensive disorders. Best Pract Res Clin Obstet Gynaecol. 2011 Aug;25(4):391–403.

  • Lana S, Lemowan E, Granger JP, Carmanche SA, Preeclampsia. Circ Res 2019 Mar 29;124(7):1094–112.

  • Kim KJ, Cho CS, Kim Woo. Role of placental growth factor in cancer and inflammation. Exp Mol Med. 2011;44(1):10.

    Articles Google Scholar

  • Kim JS, Kang EJ, Woo OH, Park KH, Woo SU, Yang DS, et al. Preeclampsia, hypertensive syndrome of pregnancy, and association with maternal breast cancer risk: a meta-analysis. Akta Onkol (Maddle). 2013 Nov;16(8):1643–8.

  • Morris P, Leary A, Creutzberg C, Abu Rustam N, Dalai E. Endometrial cancer. lancet. 2016 Mar;387(10023):1094–108.

  • Wan J, Hu Z, Zeng K, Ying Y, Zhao M, Chen M et al. Reduced circulating levels of estrogen and progesterone in preeclamptic women. gestational hypertension. January 2018; 1:11:18–25.

  • Chowdhury S, Ferdous J, Nahar KN, Mahmood S. Maternal serum progesterone levels in pre-eclampsia. Bangabandhu Sheikh Mujib Medical College Journal. 2020 February;19(1):9–12.

  • Ingec M, Gursoy HG, Yildiz L, Kumtepe Y, Kadanali S. Serum levels of insulin, IGF-1, and IGFBP-1 in preeclampsia and eclampsia. Int J Gynecol Obstet. 2004;84(3):214–9.

    Articles CAS Google Scholar

  • Kumar S, Gordon GH, Abbott DH, Mishra JS. Androgens in maternal vascular and placental function: implications for pre-eclampsia pathogenesis. 156 volumes. Reproduction. Bioscientifica Inc.; 2018. Pages R155–67.

  • Gibson DA, Schitzderis I, Collins F, Saunders PTK. Evidence for androgen action in endometrial and ovarian cancer. Endocrine-related cancers. Volume 21. BioScientifica Ltd. 2014.

  • Hallum S, Pinborg A, Kamper-Jørgensen M. Long-term effects of pre-eclampsia on maternal endometrial cancer risk. BrJ cancer. 1 March 2016;114(7):809–12.

  • Trabert B, Troisi R, Grotmol T, Ekbom A, Engeland A, Gissler M, et al. Association of pregnancy-related factors and birth characteristics with endometrial cancer risk: a Nordic population-based case-control study. International J cancer. 2020 Mar;15(6):1523–31.

  • Moher DLATJ et al. Reportable items recommended for systematic review and meta-analysis: PRISMA statement. BMJ. 21 July 2009;339(b2535).

  • Page MJ, McKenzie JE, Bosuyt PM, Boutron I, Hoffmann TC, Mulrow CD and others. PRISMA 2020 Statement: Updated guidelines for reporting systematic reviews. BMJ. 2021 March 29; n71.

  • McMenamin U, Herink K. Preeclampsia and endometrial cancer risk during pregnancy: a systematic review and meta-analysis. PROSPERO Available from:

  • Stroop DF, Berlin JA, Morton SC, Orkin I, Williamson GD, Rennie D et al. Proposals for a meta-analysis report of observational studies in epidemiology. JAMA April 2008 283(15).

  • Improving healthcare in Scotland. Scottish University Guidelines Network. Accessed March 31, 2022.

  • GA Wells BSDOJPVWMLPT. Newcastle Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. Accessed March 29, 2022.

  • Simmons MJ, Moore DT. Risk ratios and prospective epidemiological studies. J Clin Epidemiol. 2002 Sep;55(9):893–9.

  • Ranganathan P, Aggarwal R, Pramesh C. Common pitfalls in statistical analysis: odds and risks. Perspective Clinical Institute 2015;6(4):222.

    Articles PubMed PubMed Central Google Scholar

  • Higgins JPT, Thompson SG. Quantification of heterogeneity in meta-analyses. statistical medicine. 2002 Jun;15(11):1539–58.

  • Walfisch A, Kessous R, Davidson E, Sergienko R, Sheiner E. Preeclampsia and future female malignancies. hypertension, pregnancy. 2015 Oct 2;34(4):456–63.

  • Bhattacharya S, Prescott GJ, Iversen L, Campbell DM, Smith WCS, Hannaford PC. Hypertensive disorders of pregnancy and future health and mortality: A documented association study. gestational hypertension. 2012 Jan;2(1):1–7.

  • Mogren I, Stenlund H, Högberg U. Long-term effects of reproductive factors on cervical, endometrial, ovarian and breast cancer risk. Akta Onkol (Maddle). 2001;40(7):849–54.

    Articles CAS Google Scholar

  • Calderon-Margalit R, Friedlander Y, Yanetz R, Deutsch L, Perrin MC, Kleinhaus K, et al. Preeclampsia and Subsequent Cancer Risk: Updates from the Jerusalem Perinatal Study. I am J Obstett Gynecologist. 2009;200(1):63.e1-63.e5

    Articles Google Scholar

  • Cho HW, Ouh YT, Lee KM, Han SW, Lee JK, Cho GJ et al. Long-term effects of pregnancy-related factors on the development of endometrial tumors: a national retrospective cohort study. PLoS One. 1 March 2019;14(3).

  • Liu Y, Chen X, Sheng J, Sun X, Chen GQ, Zhao M, et al. Pregnancy complications and risk of developing endometrial or ovarian cancer: a case-control study. Front End Crinol (Lausanne). 2021 April 30;12.

  • Bokhman J. Two pathogenic types of endometrial cancer. Guinekol Onkol 1983 Feb;15(1):10–7.

  • Suarez AA, Felix AS, Cohn DE. Bokhman Redux: The ‘Types’ of Endometrial Cancer in the 21st Century. Guinecol Oncol. 2017 Feb;144(2):243–9.

  • World Cancer Research Fund International. World Cancer Research Fund. diet, nutrition, physical activity, endometrial cancer. The third. Vol. 1. 2018. 17–20.

  • Doherty MT, Sanni OB, Coleman HG, Cardwell CR, Glenn McCluggage W, Quinn D, et al. Concomitant and future risk of endometrial cancer in women with endometrial hyperplasia: a systematic review and meta-analysis. 15 volumes. PLoS ONE. Public Science Library;; 2020.

  • Achromite MT, Mantzoros CS, Leach RE, Hurwitz J, Dolly LG. Androgens in pre-eclampsia. 1999.

  • Haehnel MEMJMC et al. Metabolism of androstenedione by placental microsomes in gestational hypertension. Kling Chim Acta. 1989; 181:103–8.

    Papers PubMed Google Scholar

  • Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, and others. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation on Cancer and Nutrition (EPIC). Endocrine related to cancer. 2008 June;15(2):485–97.

  • Batista CG, Batista MC, Trottier A, Bairajon JP. Hyperinsulin and androgenism in women with polycystic ovary syndrome. Vol. 122, Journal of Steroid Biochemistry and Molecular Biology. 2010.p. 42-52.

  • Michels KA, Brinton LA, Wentzensen N, Pan K, Chen C, Anderson GL and others. Postmenopausal androgen metabolism and endometrial cancer risk in the Women’s Health Initiative observational study. JNCI Cancer Spectrum. September 2019 1;3(3).

  • Cornelius DC, Preeclampsia. From inflammation to immunomodulation. Clin Med Insights Blood Disorders. 2018 1 1;11.

  • Wang T, Rohan TE, Gunter MJ, Xue X, Wactawski-Wende J, Rajpathak SN, et al. A prospective study of inflammatory markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomarker 2011 May;20(5):971–7.

  • Trabert B, Eldridge RC, Pfeiffer RM, Shields MS, Kemp TJ, Guilmet C, et al. Prediagnostic Circulating Inflammatory Markers and Endometrial Cancer Risk in Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trials . International J cancer. 2017 Feb 1;140(3):600–10.

  • Dossus L, Becker S, Rinaldi S, Lukanova A, Tjønneland A, Olsen A, et al. Tumor necrosis factor (TNF)-α, soluble TNF receptors, and endometrial cancer risk: an EPIC study. International J cancer. 2011 Oct;15(8):2032–7.

  • Serrand C, Mura T, Fabbro-Peray P, Seni G, Mousty È, Boudemaghe T and others. Evaluation of the incidence of all-cause cancer in individuals with pre-eclampsia or eclampsia during their first pregnancy. JAMA net opened. 2021 June 23;4(6):e2114486.

  • Wang F, Zhang W, Cheng W, Huo N, Zhang S. Preeclampsia and cancer risk in late-life women: a systematic review and meta-analysis of cohort studies. menopause. 2021 Sep;28(9):1070–8.

  • Ranari C, Molinoro AA. Progesterone Receptor—Cell Signaling in Animal Models and Breast Cancer. Diverse Activation Pathways of Progesterone Receptors—Possible Effects on Breast Biology and Cancer. breast cancer research. 1 December 2002;4(6):240.

  • Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *